The quest to find treatment by 2030: How our collaborative approach is accelerating the development of new treatments for MND

Does a treatment for motor neurone disease (MND) by 2030 sound far-fetched to you? Here's why it's not.

Join Rob Smith and LifeArc business manager Cornelia "Conny" Roesl as they navigate the finer points of the groundbreaking MND Collaborative Partnership.

They discuss, among other things, which areas of research the collaboration is targeting, how it is co-ordinated, why it's so different from what has come before, and the planned timescales for an effective MND treatment by 2030.